More articles from 1.5 Diffuse Parenchymal Lung Disease

Natural killer and natural killer T-like cells in bronchoalveolar lavage fluid and peripheral blood in diffuse lung diseases
Eva Padrão, Oksana Sokhatska, Marília Beltrão, Carmo Palmares, Patrícia Caetano Mota, Natália Melo, António Morais, Luís Delgado

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3097; DOI: 10.1183/13993003.congress-2016.PA3097
Combining immunostaining with micro-computed tomography to visualise the 3D distribution of mast cells in idiopathic pulmonary fibrosis
Ahmad Elmansouri, James Cairns, Philipp Schneider, Ian Sinclair, Luca Richeldi, Peter Lackie, Mark G. Jones, Jane A. Warner

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3091; DOI: 10.1183/13993003.congress-2016.PA3091
Role of MUC1 in idiopathic pulmonary fibrosis
Beatriz Ballester, Javier Milara, Celia Sanz, Sonia González, Ricardo Guijarro, Cecilia Martínez, Julio Cortijo

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3087; DOI: 10.1183/13993003.congress-2016.PA3087
Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Piotr Kopinski, Ewa Wypasek, Andrzej Dyczek, Joanna Golinska, Tomasz Wandtke, Adam Szpechcinski, Joanna Chorostowska-Wynimko

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3100; DOI: 10.1183/13993003.congress-2016.PA3100
Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease
Elizabeth Redente, Martin Aguilar, Luc Lalire, Benjamin Edelman, Lutz Wollin, David Riches

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3089; DOI: 10.1183/13993003.congress-2016.PA3089
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Karina Portillo Carroz, Iñaki Salvador-Corres, Eva Martinez -Cáceres, Carmen Centeno-Clemente, Aina Teniente-Serra, Juan Ruiz -Manzano, Alejandro Olivé-Marques

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3102; DOI: 10.1183/13993003.congress-2016.PA3102
Studies on apoptosis of alveolar lymphocytes (AL) in exogenous allergic alveolitis (EAA)
Piotr Kopinski, Grzegorz Przybylski, Andrzej Dyczek, Ewelina Wedrowska, Joanna Golinska, Adam Szpechcinsk1, Joanna Chorostowska-Wynimko

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3101; DOI: 10.1183/13993003.congress-2016.PA3101
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Masakiyo Yatomi, Takeshi Hisada, Yoshimasa Hachisu, Yasuyuki Saito, Hiroaki Tsurumaki, Yosuke Kamide, Haruka Aoki-Saito, Yasuhiko Koga, Akihiro Ono, Kunio Dobashi, Tamotsu Ishizuka, Masanobu Yamada, Fumikazu Okajima

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3094; DOI: 10.1183/13993003.congress-2016.PA3094
Tumor necrosis factor-alpha and CD4/CD8 ratio in patients with hypersensitivity pneumonitis
Alaa Rashad Mahmoud, Asmaa Nafady

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3104; DOI: 10.1183/13993003.congress-2016.PA3104
Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Sana Bahri, Ridha Ben Ali, Khaoula Gasmi, Mona Mlika, Saloua Fazaa, Riadh Ksouri, Raja Serairi, Saloua Ben Khamsa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA3103; DOI: 10.1183/13993003.congress-2016.PA3103

Main menu

User menu

Search

More articles from 1.5 Diffuse Parenchymal Lung Disease

Pages

Contact us